Unlearn AI
What They Do
Generates AI digital twins from clinical data to optimize clinical trials. Uses patient longitudinal data for prediction and generates synthetic control arms, reducing trial sizes and timelines.
AIDAVA Relevance
Longitudinal patient data for digital twins, synthetic data generation
Funding
Valuation: ~$200M+ (est.) $50M+
Business Details
- Founded: 2019
- Total Funding: $50M Series C
- Valuation: ~$200M+ (est.)
- Revenue: N/A (private)
- Employees: ~50-100 (est.)
- Key Milestones: $50M Series C. Digital twins for clinical trials. Applied to VectorY PIONEER-ALS study.